Sint Antonius Ziekenhuis Stichting — Clinical Trial Site

90 Registered trials

44 Currently recruiting

Organisation

Sint Antonius Ziekenhuis Stichting

Location

Nieuwegein, Netherlands

Identifier

ORG-100021158

Address

Koekoekslaan 1, 3435 CM, Netherlands

Departments

Afd. Interne geneeskunde
Afdeling Longziekten
Anaesthesia
Cardiology
Clinical neurophysiology
Department of Internal Medicine
gastorenterology
Gastroenterology & Hepatology
Gastroenterology and hepatology
hematology
ICU
Internal Medicine
Internal Medicine - Hematology
Internal Medicine - Nephrology
Internal medicine, medical oncology
Internal Medicine, nephrology
Internal Medicine/Hematology
Interne Geneeskunde
Interne geneeskunde, medische oncologie
Interne Geneeskunde/nefrologie
Longcentrum
Longziekten
MDL
Medical Oncology
Medische oncologie
Neurology
Nuclear Medicine
Nuclear Radiology
Obstetrics & Gynecology
Oncologie
Ophthalmology
Paediatric Gastroenterology
Polikliniek Longziekten
Psychiatrie en medische psychologie
Pulmonary Department
Pulmonary Science
Pulmonology
Reproductive medicine and gynecology
Surgery
urology

Clinical trials at this site (90)

Search interface

Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Advanced tumors 5 2018-08-24
A Phase 2 Study of CAL101 in Patients with Idiopathic Pulmonary Fibrosis Ended

2024-518339-12-00 Idiopathic Pulmonary Fibrosis 4 2025-07-08
A clinical study of sotatercept in people with pulmonary arterial hypertension Ended

2024-518687-12-00 Pulmonary Arterial Hypertension (PAH) 4 2025-06-19
Multi-institutional Evaluation of the Cost-effectiveness of PSMA-PET/CT for the Detection of Pelvic Lymph Node Invasion in Newly Diagnosed P… Ended

2024-518171-59-00 Prostate Cancer 11 2025-01-23
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Capsules Compared to Intravenously (IV) Infused Rituximab Plus IV Infu… Ended

2024-510965-41-00 Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymph 5 2024-09-03
MAD Ended

2024-516379-34-00 Myopia 6 2024-08-02
Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease Ended

2023-504471-25-00 Fibrotic Lung Disease 5 2024-03-01
Does progesterone luteal phase support increase live birth rates in couples undergoing intra-uterine insemination with Mild Ovarian HyperSti… Ended

2022-501534-33-00 Unexplained Subfertility, infertility 6 2023-03-06
Impact of peri-operative tEstosterone levels oN Functional and oncological Outcomes following RadiCal prostatEctomy Ended

2024-511340-29-02 Late-onset hypogonadism 5 2022-12-14
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
SEQUEL-Breast: a phase 2 study on the combination of alpelisib and fulvestrant after progression on previous therapy with fulvestrant in pat… Ended

2024-514965-20-00 Breast cancer 4 2022-06-02
Lutetium after second-line hormonal treatment [PBP-301] [SPLASH] Ended

2024-515604-39-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2022-01-28
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
A Clinical trial to compare the combination of Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone versus the combination of Carfilzomib-Lenal… Ended

2024-513422-38-00 Newly diagnosed multiple myeloma 5 2020-09-28
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17
A Phase 3 study to compare long-term efficacy and safety of macitentan 75 mg versus 10 mg in Pulmonary Arterial Hypertension. Ended

2024-515669-32-00 Pulmonary arterial hypertension 5 2020-06-30
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
A randomized phase II multicenter study to assess the tolerability and efficacy of the addition of midostaurin to 10-day decitabine in unfit… Ended

2023-503829-18-00 Acute myeloid leukemia 4 2019-12-05
Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended

2023-509287-26-00 previously untreated metastatic or locally advanced eso 4 2019-07-01
Image‐guided de‐escalation of neoadjuvant chemotherapy in HER2‐positive breast cancer: the TRAIN‐3 study Ended

2024-516205-23-00 Breast cancer 4 2019-04-09
DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ended

2024-513867-19-00 metastatic Castration-Resistant Prostate Cancer (mCRPC) 5 2019-01-31
HOVON 151 DLBCL: A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diff… Ended

2022-501076-26-00 high risk diffuse large B-cell lymphoma 4 2018-08-28
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
CRITICS-II Ended

2023-503248-15-00 Patients with TNM 8th ed stage IB-IIC gastric adenocaci 4 2017-10-09